Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
They may replace 70% of chemical drugs in the next two decades
R4BP 3.3 now has updated functionalities to help both industry and authorities make better use of their time, multitask, and meet their regulatory obligations
Cannabis has a long history of therapeutic as well as recreational use. Dr Sarah Houlton considers the properties that are making it increasingly attractive to pharma companies now that its legalisation is accelerating
This is the company's sole manufacturing site for amoxicillin, the API used in antibiotics
Also has a two-layer construction that offers enough space for product information
The poor solubility and bioavailability of today’s APIs can be addressed via micronisation. Swiss group Dec looks at the latest technology for reducing the particle size of potent APIs
New freeze-drying system is offered in a vertical configuration for the production of cancer drugs
Continuous improvements in growth media and cell lines have elevated biomass concentrations in bioprocesses, subsequently challenging the downstream purification process. Sartorius Stedim Biotech’s body feed filtration-based solution is designed to address this issue
Aim to deliver productivity advice, as well as providing equipment modifications to bespoke machinery to cover all major pharma line providers
Biotechnology has changed healthcare radically over the past decade and its impact on the pharmaceutical sector is growing. Susan Birks reports on the impact of the biotech boom
The 12-month project involved the design and construction of two temperature-controlled self-supporting structures
Evaluation of extractables and leachables (E&L) is an important aspect of the FDA’s Quality by Design initiative in drug design. But there are, as yet, no exact details on how to set up a suitable study strategy. Andreas Nixdorf, SGS Life Science Services, discusses general approaches and cornerston